{
  "docId": "019de073-d546-7099-b69b-fc409bd054ba",
  "docSlug": "a8472da99eed55bdf1e59eb3c42372d9",
  "documentTitle": "Silo Pharma | Investor Presentation Deck | 24 slides",
  "authorId": "silo-pharma",
  "authorName": "Silo Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 24,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Slide 20 of the deck.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-d546-7099-b69b-fc409bd054ba/20",
  "deckHref": "/decks/019de073-d546-7099-b69b-fc409bd054ba",
  "deckJsonHref": "/decks/019de073-d546-7099-b69b-fc409bd054ba.json",
  "deckAnchorHref": "/decks/019de073-d546-7099-b69b-fc409bd054ba#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.12,
        "x": 0.85,
        "y": 0.03
      },
      "kind": "image",
      "text": "SiloPharma",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ced7d057-4a95-469a-ba45-74c1bc5413de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.8,
        "x": 0.105,
        "y": 0.27
      },
      "kind": "list",
      "text": "505(b)(2) regulatory pathway provides competitive time-to-market advantage over other early psychedelic drug market entrants. Diversified pipeline drugs showing promise in underserved rare disease, neurological, and mental health indications. Massive addressable market projected to grow at a 17% CAGR to $9.8 billion in 2029. Assets well protected with more than five issued and provisional patents and four patent applications pending. Ample capital resources to support upcoming catalysts. Deep expertise and strong governance through highly credentialed management, board, and advisory.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80538cbf-f3a6-4f44-8fb0-b2e1495be66f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.01,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Data Bridge Market Research, September 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb496367-e727-4171-8f27-06eab35bd0f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.26,
        "x": 0.105,
        "y": 0.135
      },
      "kind": "title",
      "text": "Business Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ab65e59-3117-4588-8350-5532d5d06be7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "f38406c2-9306-4f91-9d56-7cdc99b2e914",
      "evidence": "This slide serves as a brief overview of the company's business highlights.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}